Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23767452 | DQ8 (HAPLOTYPE) | food intolerance | NA | NA | NA | unclassified | |
| the symptoms of gluten sensitivity may also have another genetic background of food intolerance independent of the hladq2, - dq8 system and tissue transglutaminase (eg. | |||||||
| 24033735 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | retinopathy of prematurity | NA | NA | NA | unclassified | |
| the role of the human leukocyte antigen system in retinopathy of prematurity: a pilot study. | |||||||
| 24033735 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | retinopathy of prematurity | NA | NA | NA | only_studied | |
| aimto assess the association between the human leukocyte antigen system and retinopathy of prematurity. | |||||||
| 24033735 | HLA (HLA) | retinopathy of prematurity | NA | NA | NA | unclassified | |
| the results suggest that the hla system may be associated with the development of retinopathy of prematurity. | |||||||
| 24236482 | HLA (HLA) | zonisamide | Japanese | phenobarbital | NA | unclassified | |
| NA | |||||||
| 25327504 | HLA-B*44 | lamotrigine | Korean | acetazolamide | NA | unclassified | |
| NA | |||||||
| 24635066 | HLA-A*31 | phenytoin | NA | carbamazepine | NA | unclassified | |
| NA | |||||||
| 31206740 | HLA-B*56 | drug reaction with eosinophilia and systemic symptoms | Non European | phenytoin | NA | unclassified | |
| high and variable population prevalence of hla-b*56:02 in indigenous australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms. | |||||||
| 31206740 | HLA-B*56 | drug reaction with eosinophilia and systemic symptoms | Non European | phenytoin | NA | positive | |
| phenytoin drug reaction with eosinophilia and systemic symptoms (dress) in 3 aboriginal australians positive for hla-b*56:02 has been previously reported. | |||||||
| 32791162 | HLA-B*13 | co-trimoxazole | Asian | sulfonamide | rs41554616 | unclassified | |
| NA | |||||||
Copyright 2024